1. Home
  2. Analysis
  3. Veltassa
  4. Detrol

Veltassa and Detrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veltassa (patiromer sorbitex calcium) and Detrol (tolterodine tartrate). Common drug interactions include diarrhoea among females and abdominal mass among males.

The phase IV clinical study analyzes what interactions people have when they take Veltassa and Detrol. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Veltassa?

Veltassa has active ingredients of patiromer sorbitex calcium. eHealthMe is studying from 15,649 Veltassa users. Check the latest studies of Veltassa.

What is Detrol?

Detrol has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 28,669 Detrol users. Check the latest studies of Detrol.

On Jul, 30, 2026

15 people who take Veltassa and Detrol together, and have interactions are studied.

Veltassa and Detrol drug interactions.

What are the common drug interactions of Veltassa and Detrol, by gender? *:

female:

  1. Diarrhoea
  2. Nausea (feeling of having an urge to vomit)
  3. Rash pruritic (redness with itching)
  4. Vomiting
  5. Drug intolerance (drug sensitivity)
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Insomnia (sleeplessness)
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Emergency care
  10. Hypotension (abnormally low blood pressure)

male:

  1. Abdominal mass (localized enlargement or swelling in the human abdomen)
  2. Abdominal pain
  3. Constipation
  4. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  5. Hypertension (high blood pressure)
  6. Hypokalaemia (low potassium)
  7. Urinary tract infection

What are the common drug interactions of Veltassa and Detrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Constipation
  2. Adverse drug reaction
  3. Urinary tract infection
  4. Emergency care
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Pruritus (severe itching of the skin)
  7. Abdominal mass (localized enlargement or swelling in the human abdomen)
  8. Abdominal pain
  9. Drug intolerance (drug sensitivity)
  10. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)

What are the existing conditions these people have? *

  1. Hyperkalemia (damage to or disease of the kidney): 15 people, 100.00%
  2. Stress And Anxiety: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Veltassa and Detrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Veltassa and Detrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Veltassa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Detrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Veltassa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Detrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on patiromer sorbitex calcium and tolterodine tartrate (the active ingredients of Veltassa and Detrol, respectively), and Veltassa and Detrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.